Current News

Perhaps you have already visited our FAQ area?

Less than 1.5 years remain for pharmaceutical companies to implement the complex requirements from the Delegated Regulation

The new guideline of the EMVO shall facilitate the connection to the EU hub for pharmaceutical companies

ACS PharmaProtect GmbH would like to invite all companies already contractually connected to this seminar on December 07, 2017

The 10th securPharm / ACS PharmaProtect knowledge sharing lesson will take place for our contract partners

New version 2.03 of the coding rules was published on May 05, 2017 by securPharm e.V.

You already concluded a contract with EMVO for the connection to the European hub? Then you have done the first step.

After the publication of the Delegated Regulation (EU) 2016/161 on February 9, 2016, the pharmaceutical companies have less than 2 years left to implement the requirements arising out of the FMD.

As already announced, ACS PharmaProtect GmbH organizes on May 9, 2017 in the time from 10.00 a.m. till app.4.45 p.m. the seminar “Falsification protection made easier “. 

The Delegated Regulation (EU) 2016/161 requires that after February 9, 2019 only prescription medicines which bear the new safety features may be put into circulation